Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockbuphoonon Jul 20, 2021 4:21pm
95 Views
Post# 33576659

Not one person on here is buying - including the pumper

Not one person on here is buying - including the pumper

Pumperboy (realstocky/tommyjones/newcamo) are all the same guy as witnessed by their spelling of incorrect spelling of Ryplayim. Must be dyslexic or something. Then, there's the spelling of sur, gona, negociate, u're that are his signature incorrect spellings. So incredibly obvious.

Liminal did trade at $32 Canadian a year ago on dumb speculation that Liminal had a COVID-19 plasma therapy which was completely false. Pumperboy was pumping $50 easy price and probably $100 at the time just to give any newbie some context.  

Since then, Liminal sold off Plasma division with an FDA approved drug Ryplazim with all that off-label potential for ARDS and severe burn applications. And then they have cancelled both their leading Fezagrapras/ 4050 indications for Phase 2 and have said nothing about many others in close to 2 months. Wait for the PR on 

Everything else is preclinical and cannot get to Phase 1 trial in next 2 years

<< Previous
Bullboard Posts
Next >>